Loading...
Loading...
Holder clone rankings through .
Of the 16 tracked institutions holding FDMT, 5 have a 3-year clone track record — 4 of them beat the S&P. Average holder's clone alpha: +1.9pt. It's a gauge of who owns the name, not just how many.
Among the 16 tracked institutional investors we monitor, FDMT (4D MOLECULAR THERAPEUTICS IN) is held with a combined value of $280.84M across 21,228,462 shares. The largest holder is RA CAPITAL MANAGEMENT, L.P. with a position worth $72.26M (0.72% of their portfolio). 2 funds opened new positions in the most recent quarter. 6 funds increased their holdings. 6 funds reduced their position.
Total Institutional Value
$280.84M
Total Shares Held
21,228,462
Institutional Holders
16
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $72.26M | 0.72% | - |
| 2 | BlackRock, Inc. | $67.61M | 0.00% | +3.9% |
| 3 | STATE STREET CORP | $35.34M | 0.00% | -15.2% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $32.76M | 0.05% | +1.8% |
| 5 | ARMISTICE CAPITAL, LLC | $27.90M | 0.94% | -2.5% |
| 6 | VANGUARD GROUP INC | $23.20M | 0.00% | +20.1% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $5.89M | 0.01% | -33.0% |
| 8 | FMR LLC | $4.46M | 0.00% | +143.1% |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | $2.33M | 0.00% | +26.7% |
| 10 | CITADEL ADVISORS LLC | $2.21M | 0.00% | -77.6% |
As of the latest SEC 13F filings, RA CAPITAL MANAGEMENT, L.P. is the largest institutional holder of FDMT with a position worth $72.26M, representing 0.72% of their portfolio. In total, 16 institutional investors hold FDMT with a combined value of $280.84M.
In the most recent quarter, 2 funds opened a new position in FDMT. Additionally, 6 increased their holdings and 6 reduced their positions.
Institutional investors hold $280.84M worth of FDMT stock across 16 positions. The largest institutional holder is RA CAPITAL MANAGEMENT, L.P. with $72.26M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For FDMT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| — |
| 7.3% |
| 2026-11-16 |
| — | 4.5% | 2026-11-10 |
SEC Schedule 13D (activist) and 13G (passive) filings for FDMT. Filed when an investor acquires 5%+ ownership.
Last Close
$10.79
2026-11-17
YTD
+47.4%
38% of 52-week range